drugset / Trial / NCT07168785

[18F]-AraG PET Imaging in LA HNSCC

NCT07168785

Phase 0 Not yet recruiting 5 enrolled Indiana University CellSight Technologies, Inc. · collab
NaSingle-groupOpen-labelDiagnostic

Summary

This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.

Timeline

Start
2025-10-01
Primary completion
2027-06
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified